A Study of Eloralintide (LY3841136) in Participants With Obesity, or Overweight Without Type 2 Diabetes (NCT07321886)
🩺 Plain-English Summary (8th-Grade Level)
The purpose of this study is to evaluate the efficacy and safety of eloralintide in adults with obesity or overweight who do not have type 2 diabetes. The study has two phases: a main phase and an extension phase. Participation in the main phase of the study will last about 75 weeks. Participants with prediabetes will continue in the extension phase for another 2 years.
Who can join: To join this study, participants generally need to meet the listed inclusion criteria (9 items) and avoid the listed exclusions (12 items).
Location: MFA Clinical Research — Tuscaloosa, Alabama
📋 "Do I Qualify?" — 1-Minute Self Screener
Instant ChecklistCheck every box below. If you can check all of them, you may meet the study's basic screening requirements (final eligibility is confirmed by the site team).
Usually NOT eligible if any of the following apply:
- Exclusion Criteria:
- Have a prior or planned surgical treatment for obesity (liposuction, cryolipolysis, or abdominoplasty allowed if performed \>1 year before screening)
- Have a prior or planned endoscopic procedure and/or device-based therapy for obesity (prior device-based therapy acceptable if device removal was more than 6 months prior to screening)
- Have type 1 diabetes or type 2 diabetes
- Have had within 90 days prior to screening:
- heart attack
- stroke
- coronary artery revascularization
- unstable angina, or
- hospitalization due to congestive heart failure
- Have a history or diagnosis of New York Heart Association Functional Classification Class IV congestive heart failure
- Have taken medications or alternative remedies intended for weight loss within 90 days of screening
🔍 Extracted verbatim from the official NIH eligibility criteria. Always confirm with the study coordinator.
📍 All Participating Trial Locations (162 Sites)
- MFA Clinical Research — Tuscaloosa, Alabama
- Headlands Research - Scottsdale — Scottsdale, Arizona
- Neighborhood Healthcare Institute of Health — Escondido, California
- Ark Clinical Research - Fountain Valley — Fountain Valley, California
- Desert Oasis Healthcare Medical Group — Palm Springs, California
- Peninsula Research Associates — Rolling Hills Estates, California
- Care Access - Sacramento — Sacramento, California
- Southern California Clinical Research — Santa Ana, California
- University Clinical Investigators, Inc. — Tustin, California
- Chase Medical Research, LLC — Waterbury, Connecticut
- JEM Research Institute — Atlantis, Florida
- BioMed Research & Medical Center — Miami, Florida
- Adult Medicine of Lake County, Inc. — Mt. Dora, Florida
- American Research Centers of Florida — Pembroke Pines, Florida
- AHF Pensacola — Pensacola, Florida
- IMA Clinical Research St. Petersburg — St. Petersburg, Florida
- Teak Research Consults - Dunwoody — Dunwoody, Georgia
- Teak Research Consults — Lawrenceville, Georgia
- Clinical Research Atlanta — Stockbridge, Georgia
- East-West Medical Research Institute — Honolulu, Hawaii
- Iowa Diabetes and Endocrinology Research Center — West Des Moines, Iowa
- Cotton O'Neil Clinical Research Center — Topeka, Kansas
- Care Access - Lake Charles (Bayou Pines) — Lake Charles, Louisiana
- MedStar Good Samaritan Hospital — Baltimore, Maryland
- MedStar Health Research Institute (MedStar Physician Based Research Network) — Hyattsville, Maryland
💰 Cost, Insurance & Patient Rights
- 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
- Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
- Voluntary Participation: You may withdraw at any time without affecting your standard medical care.